CervoMed's dementia drug fails to meet mid-stage trial goals
10/12/2024 12:09
Dec 10 (Reuters) - CervoMed CRVO.O said on Tuesday that its experimental drug for a form of dementia did not meet the main or secondary goals in mid-stage clinical trial. (Reporting by Kamal Choudhury in Bengaluru; Editing by Anil D'Silva) ((Kamal.Choudhury@thomsonreuters.com;))